Under-the-radar drug stock has big rebound potential here despite turmoil, says Carter Worth
Carter breaks down the charts on large-cap pharmaceutical manufacturer AbbVie.
since
auto-detected in 25 stories
22 days ago
24 days ago
page 1 of 1